James M. Ellison, MD, MPH

December 03, 2020

The authors make the case for national education mandates from accreditation organizations and congressional support to require enhanced education of all clinicians who care for older adults.

May 17, 2019

A lively ongoing debate is examining the ethics and legality of age-based evaluation of clinicians.

January 26, 2017

“Doctor, will you prescribe medical marijuana for my mother? I think it might help her agitation better than the medication you gave her last visit.”

May 13, 2016

Depression can be accompanied by cognitive symptoms, but the nature of the relationship between these symptom categories is multifaceted.

May 14, 2015

In order for older patients to derive greater enjoyment from their later years, clinicians must take special care during evaluation, treatment, and follow up when working with this growing population.

June 17, 2014

Mood disorders in older adults are neither inevitable nor particularly resistant to treatment. With attention to the special needs of older patients during evaluation, treatment, and follow up, clinicians can help many patients derive greater enjoyment from their later years.

April 15, 2014

Placing black floor mats in front of exits to deter demented nursing home residents from dangerous wandering may pose ethical questions.

July 28, 2012

Of the 3 informative articles included in this special geriatric collection, 1 offers a perspective on the treatment of depression that does not focus on somatotherapy. The others remind us of 2 additional geriatric Ds of importance: drugs and driving.

October 01, 2008

When I was recently asked by a patient about the link between osteoporosis and SSRIs, I dimly recalled this topic’s emergence in a medical journal in 2007, its subsequent meander through several newsletters, and its gradual return to the bottom of my mental risk-assessment checklist.

May 02, 2008

One recent survey found that more than 1 in 4 patients who have mild cognitive impairment (MCI) were receiving cholinesterase inhibitors in Italian AD treatment centers even though these medications were being used "off-label."